Apovincamine
| Code | Size | Price |
|---|
| TAR-T21047-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Apovincamine is a vinca alkaloid and a chemical precursor of Vinpocetine, which is a derivative of Vincamine with vasodilating activity.
CAS:
4880-92-6
Formula:
C21H24N2O2
Molecular Weight:
336.435
Purity:
0.98
SMILES:
CC[C@]12CCCN3CCc4c([C@H]13)n(C(=C2)C(=O)OC)c1ccccc41
References
1. Solovyeva EY, Karneev AN, Chekanov AV, Baranova OA, Choi IV. [Complex application 2-ethyl-6-methyl-3-hydroxypyridine-succinate and vinpocetine in cerebrovascular disorder.]. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(5):103-108. doi: 10.17116/jnevro201711751103-108. Review. Russian. PubMed PMID: 28638040.
2. Feher G, Koltai K, Kesmarky G, Horvath B, Toth K, Komoly S, Szapary L. Effect of parenteral or oral vinpocetine on the hemorheological parameters of patients with chronic cerebrovascular diseases. Phytomedicine. 2009 Mar;16(2-3):111-7. doi: 10.1016/j.phymed.2008.10.014. Epub 2009 Jan 8. PubMed PMID: 19135345.
3. Szatmari SZ, Whitehouse PJ. Vinpocetine for cognitive impairment and dementia. Cochrane Database Syst Rev. 2003;(1):CD003119. Review. PubMed PMID: 12535455.
4. Jucker M, B?ttig K, Meier-Ruge W. Effects of aging and vincamine derivatives on pericapillary microenvironment: stereological characterization of the cerebral capillary network. Neurobiol Aging. 1990 Jan-Feb;11(1):39-46. Erratum in: Neurobiol Aging 1990 Nov-Dec;11(6):675. PubMed PMID: 2325815.